131 related articles for article (PubMed ID: 37225494)
21. Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment.
Chen CS; Jian MJ; Chang CK; Chung HY; Li SY; Lin JC; Yeh KM; Yang YS; Chen CW; Hsieh SS; Tang SH; Perng CL; Chang FY; Shang HS
PeerJ; 2023; 11():e14666. PubMed ID: 36710871
[TBL] [Abstract][Full Text] [Related]
22. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
Abdullah F; Myers J; Basu D; Tintinger G; Ueckermann V; Mathebula M; Ramlall R; Spoor S; de Villiers T; Van der Walt Z; Cloete J; Soma-Pillay P; Rheeder P; Paruk F; Engelbrecht A; Lalloo V; Myburg M; Kistan J; van Hougenhouck-Tulleken W; Boswell MT; Gray G; Welch R; Blumberg L; Jassat W
Int J Infect Dis; 2022 Mar; 116():38-42. PubMed ID: 34971823
[TBL] [Abstract][Full Text] [Related]
23. Coronavirus Disease 2019 (COVID-19) Perinatal Outcomes Across the Pandemic at an Academic Medical Center in New York City.
Seaton CL; Cohen A; Henninger EM; Gendlina I; Hou W; Bernstein PS; Duong TQ
Obstet Gynecol; 2023 Jan; 141(1):144-151. PubMed ID: 36302251
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.
Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY
Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841
[TBL] [Abstract][Full Text] [Related]
25. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of influenza and COVID-19 inpatients in different phases of the SARS-CoV-2 pandemic: a single-centre retrospective case-control study.
Bechmann L; Esser T; Färber J; Kaasch A; Geginat G
J Hosp Infect; 2023 Aug; 138():1-7. PubMed ID: 37127148
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?
Odriozola A; San Segundo D; Cuadrado A; Hernáez T; Escrich V; Fortea JI; Martínez Á; Puente Á; Lapeña B; Del Barrio M; López-Hoyos M; Crespo J; Fábrega E
Transplantation; 2022 Jul; 106(7):1445-1449. PubMed ID: 35394994
[TBL] [Abstract][Full Text] [Related]
28. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
[TBL] [Abstract][Full Text] [Related]
30. Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan.
Tomioka K; Uno K; Yamada M
Environ Health Prev Med; 2023; 28():35. PubMed ID: 37286499
[TBL] [Abstract][Full Text] [Related]
31. A descriptive study of abdominal complications in patients with mild COVID-19 presenting to the emergency department: a single-center experience in Japan during the omicron variant phase.
Maruyama S; Wada D; Oishi T; Saito F; Yoshiya K; Nakamori Y; Kuwagata Y
BMC Gastroenterol; 2023 Feb; 23(1):43. PubMed ID: 36800938
[TBL] [Abstract][Full Text] [Related]
32. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
33. Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections.
Tso WWY; Kwan MYW; Wang YL; Leung LK; Leung D; Chua GT; Ip P; Fong DYT; Wong WHS; Chan SHS; Chan JFW; Peiris M; Lau YL; Rosa Duque JS
Emerg Microbes Infect; 2022 Dec; 11(1):1742-1750. PubMed ID: 35730665
[TBL] [Abstract][Full Text] [Related]
34. Simple mathematical model for predicting COVID-19 outbreaks in Japan based on epidemic waves with a cyclical trend.
Manabe H; Manabe T; Honda Y; Kawade Y; Kambayashi D; Manabe Y; Kudo K
BMC Infect Dis; 2024 May; 24(1):465. PubMed ID: 38724890
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
36. Identifying a more severe emergent COVID-19 variant using Emergency Departments' routinely collected clinical measures.
Nyinawingeri A; Staff M
Commun Dis Intell (2018); 2023 Mar; 47():. PubMed ID: 36958931
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].
Feng Q; Wang Z; Yu H; Shi L; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):459-464. PubMed ID: 35728844
[TBL] [Abstract][Full Text] [Related]
38. [Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].
Guo X; Luo X; Wu B; Wang W; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):581-585. PubMed ID: 35924511
[TBL] [Abstract][Full Text] [Related]
39. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China.
Xu H; Li H; You H; Zhang P; Li N; Jiang N; Cao Y; Qin L; Qin G; Qu H; Wang H; Zou B; He X; Li D; Zhao H; Huang G; Li Y; Zhang H; Zhu L; Qiao H; Li H; Liu S; Gu L; Yin G; Hu Y; Xu S; Guo W; Wang N; Liu C; Gao P; Cao J; Zheng Y; Zhang K; Wang Y; Chen H; Zhang J; Mu D; Niu J
Emerg Microbes Infect; 2023 Dec; 12(1):2149935. PubMed ID: 36398721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
